{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:13:21Z","timestamp":1788441201964,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017584","name":"SRM Institute of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017584","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["RSP2024R465"],"award-info":[{"award-number":["RSP2024R465"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.compbiolchem.2024.108134","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T18:25:17Z","timestamp":1719339917000},"page":"108134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["Targeting cyclin-dependent kinase 2 CDK2: Insights from molecular docking and dynamics simulation\u00a0\u2013 A systematic computational approach to discover novel cancer therapeutics"],"prefix":"10.1016","volume":"112","author":[{"given":"Bharath Kumar","family":"Chagaleti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantha Kumar","family":"B.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"G.V.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajakrishnan","family":"Rajagopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Alfarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesu","family":"Arockiaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathiravan","family":"Muthu Kumaradoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Karthick Raja Namasivayam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiolchem.2024.108134_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136692","article-title":"The anti-breast cancer activity of indeno[1,2-b]pyridin-5-one and their hydrazonal precursors endowed with anti-CDK-2 enzyme activity","volume":"1295","author":"Al-Hussain","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib2","article-title":"Synthesis and antiproliferative activity studies of new functionalized pyridine linked thiazole derivatives","volume":"14","author":"Alqahtani","year":"2020","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib3","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.2174\/1871520622666220501162351","article-title":"Role of collagen regulators in cancer treatment: a comprehensive review","volume":"22","author":"Angre","year":"2022","journal-title":"Anticancer. Agents Med. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib4","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1063\/1.476722","article-title":"A new inhomogeneity parameter in density-functional theory","volume":"109","author":"Becke","year":"1998","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/07391102.2023.2193985","article-title":"An overview of mechanism and chemical inhibitors of shikimate kinase","author":"Chagaleti","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib6","doi-asserted-by":"crossref","first-page":"33770","DOI":"10.1039\/D3RA05672D","article-title":"Exploring cyclin-dependent kinase inhibitors: a comprehensive study in search of CDK-6 inhibitors using a pharmacophore modelling and dynamics approach","volume":"13","author":"Chagaleti","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib7","article-title":"Roscovitine in cancer and other diseases","volume":"3","author":"Cicenas","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1158\/1541-7786.MCR-15-0360","article-title":"Cyclin A2 and CDK2 as novel targets of aspirin and salicylic acid: a potential role in cancer prevention","volume":"14","author":"Dachineni","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131285","article-title":"Design, synthesis, anticancer evaluation and molecular docking study of novel 2,4-dichlorophenoxymethyl-based derivatives linked to nitrogenous heterocyclic ring systems as potential CDK-2 inhibitors","volume":"1247","author":"El-Sayed","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/anie.198208013","article-title":"The role of frontier orbitals in chemical reactions (Nobel Lecture)","volume":"21","author":"Fukui","year":"1982","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib11","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1039\/C9NJ03353J","article-title":"In silico study of 3-hydroxypyrimidine-2,4-diones as inhibitors of HIV RT-associated RNase H using molecular docking, molecular dynamics, 3D-QSAR, and pharmacophore models","volume":"43","author":"Gao","year":"2019","journal-title":"N. J. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib12","doi-asserted-by":"crossref","first-page":"38079","DOI":"10.1039\/D1RA07377J","article-title":"Docking studies and molecular dynamics simulation of triazole benzene sulfonamide derivatives with human carbonic anhydrase IX inhibition activity","volume":"11","author":"Gopinath","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1039\/D2CB00201A","article-title":"Emerging approaches to CDK inhibitor development, a structural perspective","volume":"4","author":"Hope","year":"2023","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib14","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ejmech.2009.12.026","article-title":"Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors","volume":"45","author":"Ibrahim","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib15","doi-asserted-by":"crossref","first-page":"W593","DOI":"10.1093\/nar\/gkac389","article-title":"PrankWeb 3: accelerated ligand-binding site predictions for experimental and modelled protein structures","volume":"50","author":"Jakubec","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.59467\/IJHC.2023.33.43","article-title":"In silico design and synthesis of some new imidazole derivatives for tuberculosis","volume":"33","author":"Jena","year":"2023","journal-title":"Indian J. Heterocycl. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejmech.2014.08.047","article-title":"Synthesis of novel 1,2,4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents","volume":"86","author":"Kamel","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136358","article-title":"Novel pyridine-thiazolidinone-triazole hybrid glycosides targeting EGFR and CDK-2: design, synthesis, anticancer evaluation, and molecular docking simulation","volume":"1294","author":"Kassem","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128823","article-title":"Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein","volume":"1221","author":"Kulkarni","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib20","first-page":"153","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat. Rev. Cancer 2009 93"},{"key":"10.1016\/j.compbiolchem.2024.108134_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/ar0201198","article-title":"Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials","volume":"36","author":"Meijer","year":"2003","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ph10040081","article-title":"Molecular docking and 3D-pharmacophore modeling to study the interactions of chalcone derivatives with estrogen receptor alpha","volume":"10","author":"Muchtaridi","year":"2017","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.compbiolchem.2024.108134_bib23","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1021\/jm300687e","article-title":"Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking","volume":"55","author":"Mysinger","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1080\/07391102.2020.1715259","article-title":"Pharmacophore model-based virtual screening, docking, biological evaluation and molecular dynamics simulations for inhibitors discovery against \u03b1-tryptophan synthase from Mycobacterium tuberculosis","volume":"39","author":"Naz","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jab.2017.04.004","article-title":"Design and drug-like properties of new 5-methoxysalicylaldehyde based hydrazones with anti-breast cancer activity","volume":"15","author":"Nikolova-Mladenova","year":"2017","journal-title":"J. Appl. Biomed."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.compbiolchem.2024.108134_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105184","article-title":"Thiazolidinone-linked1,2,3-triazoles with monoterpenic skeleton as new potential anticancer agents: design, synthesis and molecular docking studies","volume":"115","author":"Oubella","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib28","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.ejmech.2008.10.012","article-title":"Synthesis, antimicrobial and cytotoxic activities of 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles","volume":"44","author":"Padmavathi","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib29","doi-asserted-by":"crossref","first-page":"24291","DOI":"10.1039\/D3RA00732D","article-title":"Molecular dynamics simulation approach of hybrid chalcone\u2013thiazole complex derivatives for DNA gyrase B inhibition: lead generation","volume":"13","author":"Patan","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/978-1-0716-3311-3_16","article-title":"Web services for the prediction of ADMET parameters relevant to the design of neuroprotective drugs","author":"Perkin","year":"2023","journal-title":"Neuromethods 203"},{"key":"10.1016\/j.compbiolchem.2024.108134_bib31","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/2472555220973602","article-title":"CDK Family PROTAC profiling reveals distinct kinetic responses and cell cycle-dependent degradation of CDK2","volume":"26","author":"Riching","year":"2021","journal-title":"SLAS Discov. Adv. Life Sci. R. D."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib32","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1039\/D3RA08618F","article-title":"Ligand based pharmacophore modelling and integrated computational approaches in the quest for small molecule inhibitors against hCA IX","volume":"14","author":"Saravanan","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00889","article-title":"vNN web server for ADMET predictions","volume":"8","author":"Schyman","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejmech.2019.03.024","article-title":"Multi-target compounds acting in cancer progression: focus on thiosemicarbazone, thiazole and thiazolidinone analogues","volume":"170","author":"de Siqueira","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib35","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1039\/D0NJ06319C","article-title":"Synthesis, 3D-pharmacophore modelling and 2D-QSAR study of new pyridine-3-carbonitriles as vasorelaxant active agents","volume":"45","author":"Srour","year":"2021","journal-title":"N. J. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib36","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1016\/j.bmc.2018.05.024","article-title":"Design, synthesis and biological evaluation of pyrimidine derivatives as novel CDK2 inhibitors that induce apoptosis and cell cycle arrest in breast cancer cells","volume":"26","author":"Wang","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108134_bib37","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.3390\/ijms12107022","article-title":"Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) studies on \u03b11A-adrenergic receptor antagonists based on pharmacophore molecular alignment","volume":"12","author":"Zhao","year":"2011","journal-title":"Int. J. Mol. Sci."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927124001221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927124001221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T17:56:02Z","timestamp":1732298162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927124001221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":37,"alternative-id":["S1476927124001221"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108134","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting cyclin-dependent kinase 2 CDK2: Insights from molecular docking and dynamics simulation\u00a0\u2013 A systematic computational approach to discover novel cancer therapeutics","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108134"}}